三诺生物：累计回购15755261股 占总股本2.81%

Core Viewpoint - Sanofi Bio announced the completion of its share repurchase plan, acquiring a total of 15,755,261 shares, which represents 2.81% of its total share capital, with a total transaction amount of approximately 299.97 million yuan [1] Group 1 - The company completed its share repurchase plan as of February 13, 2026 [1] - The repurchased shares will be used for employee stock ownership, equity incentives, or convertible bond conversions [1]